| |
|
|
|
|
|
|
|||
|
Blood, 15 May 2005, Vol. 105, No. 10, pp. 4088-4095. Prepublished online as a Blood First Edition Paper on February 3, 2005; DOI 10.1182/blood-2004-05-1895.
Submitted May 18, 2004
Department of Biochemistry, University of Bristol, School of Medical Sciences, Bristol, United Kingdom * Corresponding author; email: ash.m.toye{at}bristol.ac.uk.
We have investigated the effects of co-expression of protein 4.2 and three protein 4.2 variants with band 3 in the Xenopus oocyte expression system. Normal protein 4.2 increased band 3-specific chloride transport in the oocytes. Protein 4.2 also co-immunoprecipitated with band 3 and co-localized with band 3 at the oocyte plasma membrane. The increase in band 3-mediated chloride transport and co-immunoprecipitation of protein 4.2 required the presence of the N-terminal cytoplasmic domain of band 3. Protein 4.2 also localized to the oocyte plasma membrane in the absence of band 3. The protein 4.2 variants 4.2Tozeur (Arg310Gln) and 4.2Komatsu (Asp175Tyr) had impaired ability to bind to band 3 and these variants did not localize to the oocyte plasma membrane when expressed on their own or when co-expressed with band 3. Unexpectedly, 4.2Nippon (Ala142Thr) behaved similarly to normal protein 4.2. In the absence of a crystal structure of protein 4.2, we propose a homology model of protein 4.2 based on the structure of the sequence-related protein transglutaminase. Using our results in oocytes and this homology model we speculate how these mutations affect protein 4.2 and result in hereditary spherocytosis.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||